Company Description
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument.
It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results.
Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications.
Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 149 |
| CEO | Jeffrey Hawkins |
Contact Details
Address: 29 Business Park Drive Branford, Connecticut 06405 United States | |
| Phone | 866 688 7374 |
| Website | quantum-si.com |
Stock Details
| Ticker Symbol | QSI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001816431 |
| CUSIP Number | 74765K105 |
| ISIN Number | US74765K1051 |
| Employer ID | 85-1388175 |
| SIC Code | 3829 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Alan Hawkins | President, Chief Executive Officer and Director |
| Dr. Jonathan M. Rothberg Ph.D. | Founder and Executive Director |
| Todd C. Bennett | Chief Commercial Officer |
| Todd Rearick | Chief Technology Officer |
| Lindsay Thompson | Chief Human Resources Officer |
| Katherine Atkinson | Senior Vice President of Demand Generation and Corporate Brand |
| Dr. John S. Vieceli Ph.D. | Chief Product Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 22, 2025 | SD | Form - SD |
| May 19, 2025 | 8-K | Current Report |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 15, 2025 | 8-K | Current Report |
| May 14, 2025 | SCHEDULE 13G/A | Filing |
| Apr 10, 2025 | 8-K | Current Report |
| Mar 20, 2025 | ARS | Filing |
| Mar 20, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 20, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 3, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |